Bowman CE - Search Results

1

Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.

Pirmohamed M, Arbuckle JB, Bowman CE, Brunner M, Burns DK, Delrieu O, Dix LP, Twomey JA, Stern RS. Pirmohamed M, et al. Among authors: bowman ce. Pharmacogenomics. 2007 Dec;8(12):1661-91. doi: 10.2217/14622416.8.12.1661. Pharmacogenomics. 2007. PMID: 18085998

2

TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole.

Alfirevic A, Vilar FJ, Alsbou M, Jawaid A, Thomson W, Ollier WE, Bowman CE, Delrieu O, Park BK, Pirmohamed M. Alfirevic A, et al. Among authors: bowman ce. Pharmacogenomics. 2009 Apr;10(4):531-40. doi: 10.2217/pgs.09.6. Pharmacogenomics. 2009. PMID: 19374512

3

Immunogenetics of drug-induced skin blistering disorders. Part I: Perspective.

Bowman C, Delrieu O. Bowman C, et al. Pharmacogenomics. 2009 Apr;10(4):601-21. doi: 10.2217/pgs.09.11. Pharmacogenomics. 2009. PMID: 19374517

4

Immunogenetics of drug-induced skin blistering disorders. Part II: synthesis.

Bowman C, Delrieu O. Bowman C, et al. Pharmacogenomics. 2009 May;10(5):779-816. doi: 10.2217/pgs.09.23. Pharmacogenomics. 2009. PMID: 19450129 Review.

5

Visualizing gene determinants of disease in drug discovery.

Delrieu O, Bowman C. Delrieu O, et al. Pharmacogenomics. 2006 Apr;7(3):311-29. doi: 10.2217/14622416.7.3.311. Pharmacogenomics. 2006. PMID: 16610942 Review.

6

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.

Nelson MR, Bacanu SA, Mosteller M, Li L, Bowman CE, Roses AD, Lai EH, Ehm MG. Nelson MR, et al. Among authors: bowman ce. Pharmacogenomics J. 2009 Feb;9(1):23-33. doi: 10.1038/tpj.2008.4. Epub 2008 Feb 26. Pharmacogenomics J. 2009. PMID: 18301416

7

Medical applications of haplotype-based SNP maps: learning to walk before we run.

Lai E, Bowman C, Bansal A, Hughes A, Mosteller M, Roses AD. Lai E, et al. Nat Genet. 2002 Nov;32(3):353. doi: 10.1038/ng1102-353. Nat Genet. 2002. PMID: 12410232 No abstract available.

8

Estimation strategies for reacting to the identification of an association between the genome and adverse drug reactions.

Thygesen H, Su TL, Whitehead J, Bowman C. Thygesen H, et al. J Biopharm Stat. 2011 Jan;21(1):111-24. doi: 10.1080/10543401003602615. J Biopharm Stat. 2011. PMID: 21191858

9

Action following the discovery of a global association between the whole genome and adverse event risk in a clinical drug-development programme.

Whitehead J, Kelly P, Zhou Y, Stallard N, Thygesen H, Bowman C. Whitehead J, et al. Pharm Stat. 2009 Oct-Dec;8(4):287-300. doi: 10.1002/pst.357. Pharm Stat. 2009. PMID: 19086002

10

Sequential genome-wide association studies for monitoring adverse events in the clinical evaluation of new drugs.

Kelly P, Stallard N, Zhou Y, Whitehead J, Bowman C. Kelly P, et al. Stat Med. 2006 Sep 30;25(18):3081-92. doi: 10.1002/sim.2499. Stat Med. 2006. PMID: 16397864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters